Platelets in fetal growth restriction: role of reactive oxygen species, oxygen metabolism, and aggregation. - Publication - Bridge of Knowledge

Your account

login

Search

Platelets in fetal growth restriction: role of reactive oxygen species, oxygen metabolism, and aggregation.

Abstract

Fetal growth restriction (FGR) is mainly caused by failure of the uteroplacental unit. The
exact pathogenesis remains unclear. The cause is thought to be related to abnormal platelet activation,
which may result in microthrombus formation in the small vessels of the placenta. Reactive oxygen
species (ROS) may initiate the pathological process of platelet activation. This study aimed to evaluate
selected platelet parameters in pregnancy complicated by FGR and relate them to the severity of
hemodynamic abnormalities. A total of 135 women (pregnant with FGR, with an uncomplicated
pregnancy, and non-pregnant) were enrolled to study different platelet parameters: count (PLT), mean
volume (MPV), ROS levels, intracellular oxygen level, oxygen consumption, and aggregation indices.
No abnormalities in PLT and MPV were found in the FGR group, although it revealed increased ROS
levels in platelets, lower platelet oxygen consumption, and intraplatelet deprivation. Aggregation
parameters were similar as in uncomplicated pregnancy. No significant relationships were observed
between hemodynamic abnormalities and the studied parameters. Platelets in pregnancies compli-
cated by FGR may reveal an impaired oxidative metabolism, which may, in turn, lead to oxidative
stress and, consequently, to an impaired platelet function. This study adds to the understanding of
the role of platelets in the etiology of FGR.

Citations

  • 6

    CrossRef

  • 0

    Web of Science

  • 7

    Scopus

Authors (5)

Cite as

Full text

download paper
downloaded 23 times
Publication version
Accepted or Published Version
License
Creative Commons: CC-BY open in new tab

Keywords

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
Cells no. 11, pages 1 - 13,
ISSN: 2073-4409
Publication year:
2022
DOI:
Digital Object Identifier (open in new tab) 10.3390/cells11040724
Bibliography: test
  1. Gagnon, R. Placental Insufficiency and Its Consequences. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 11 (Suppl. S1), 99-107. [CrossRef] open in new tab
  2. Figueras, F.; Gratacós, E. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol. Fetal Diagn. Ther. 2014, 36, 86-98. [CrossRef] [PubMed] open in new tab
  3. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics and the Society forMaternal- FetalMedicin. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet. Gynecol. 2019, 133, e97-e109. [CrossRef] [PubMed] open in new tab
  4. Salafia, C.M.; Minior, V.K.; Pezzullo, J.C.; Popek, E.J.; Rosenkrantz, T.S.; Vintzileos, A.M. Intrauterine Growth Restriction in Infants of Less than Thirty-Two Weeks' Gestation: Associated Placental Pathologic Features. Am. J. Obstet. Gynecol. 1995, 173, 1049-1057. [CrossRef] open in new tab
  5. Doppler Studies in Fetal Hypoxemic Hypoxia. Available online: https://sonoworld.com/client/fetus/html/doppler/capitulos- html/chapter_04.htm (accessed on 4 February 2022). open in new tab
  6. Brosens, I.; Dixon, H.G.; Robertson, W.B. Fetal Growth Retardation and the Arteries of the Placental Bed. Br. J. Obstet. Gynaecol. 1977, 84, 656-663. [CrossRef] open in new tab
  7. Khong, T.; Wolf, F.D.; Robertson, W.B.; Brosens, I. Inadequate Maternal Vascular Response to Placentation in Pregnancies Complicated by Pre-Eclampsia and by Small-for-Gestational Age Infants. Br. J. Obstet. Gynaecol. 1986, 93, 1049-1059. [CrossRef] open in new tab
  8. Giles, W.B.; Trudinger, B.J.; Baird, P.J. Fetal Umbilical Artery Flow Velocity Waveforms and Placental Resistance: Pathological Correlation. Br. J. Obstet. Gynaecol. 1985, 92, 31-38. [CrossRef] open in new tab
  9. Sheppard, B.L.; Bonnar, J. An Ultrastructural Study of Utero-Placental Spiral Arteries in Hypertensive and Normotensive Pregnancy and Fetal Growth Retardation. Br. J. Obstet. Gynaecol. 1981, 88, 695-705. [CrossRef] open in new tab
  10. Norris, L.A.; Sheppard, B.L.; Burke, G.; Bonnar, J. Platelet Activation in Normotensive and Hypertensive Pregnancies Complicated by Intrauterine Growth Retardation. Br. J. Obstet. Gynaecol. 1994, 101, 209-214. [CrossRef] open in new tab
  11. Burton, G.J.; Jauniaux, E. Pathophysiology of Placental-Derived Fetal Growth Restriction. Am. J. Obstet. Gynecol. 2018, 218, S745-S761. [CrossRef] open in new tab
  12. Ellison, P.T.; Jasienska, G. Constraint, Pathology, and Adaptation: How Can We Tell Them Apart? Am. J. Hum. Biol. 2007, 19, 622-630. [CrossRef] open in new tab
  13. Gardosi, J.; Madurasinghe, V.; Williams, M.; Malik, A.; Francis, A. Maternal and Fetal Risk Factors for Stillbirth: Population Based Study. BMJ 2013, 346, f108. [CrossRef] open in new tab
  14. Klinger, M.H.F.; Jelkmann, W. Role of Blood Platelets in Infection and Inflammation. J. Interferon Cytokine Res. 2002, 22, 913-922. [CrossRef] open in new tab
  15. Sugimura, M.; Kobayashi, T.; Shu, F.; Kanayama, N.; Terao, T. Annexin V Inhibits Phosphatidylserine-Induced Intrauterine Growth Restriction in Mice. Placenta 1999, 20, 555-560. [CrossRef] open in new tab
  16. Gordijn, S.J.; Beune, I.M.; Thilaganathan, B.; Papageorghiou, A.; Baschat, A.A.; Baker, P.N.; Silver, R.M.; Wynia, K.; Ganzevoort, W. Consensus Definition of Fetal Growth Restriction: A Delphi Procedure. Ultrasound Obstet. Gynecol. 2016, 48, 333-339. [CrossRef] open in new tab
  17. Lewandowska, M.; Sajdak, S.; Więckowska, B.; Manevska, N.; Lubiński, J. The Influence of Maternal BMI on Adverse Pregnancy Outcomes in Older Women. Nutrients 2020, 12, 2838. [CrossRef] open in new tab
  18. Komosa, A.; Rzymski, P.; Perek, B.; Ropacka-Lesiak, M.; Lesiak, M.; Siller-Matula, J.M.; Poniedziałek, B. Platelets Redox Balance Assessment: Current Evidence and Methodological Considerations. Vasc. Pharmacol. 2017, 93-95, 6-13. [CrossRef] open in new tab
  19. Gomes, A.; Fernandes, E.; Lima, J.L.F.C. Fluorescence Probes Used for Detection of Reactive Oxygen Species. J. Biochem. Biophys. Methods 2005, 65, 45-80. [CrossRef] open in new tab
  20. Dikalov, S.I.; Harrison, D.G. Methods for Detection of Mitochondrial and Cellular Reactive Oxygen Species. Antioxid. Redox Signal. 2014, 20, 372-382. [CrossRef] open in new tab
  21. Poniedziałek, B.; Nowaczyk, J.; Ropacka-Lesiak, M.; Niedzielski, P.; Komosa, A.; Pańczak, K.; Rzymski, P. The Altered Platelet Mineral Ratios in Pregnancy Complicated with Intrauterine Growth Restriction. Reprod. Toxicol. 2018, 76, 46-52. [CrossRef] open in new tab
  22. Barker, D.J.; Osmond, C.; Law, C.M. The Intrauterine and Early Postnatal Origins of Cardiovascular Disease and Chronic Bronchitis. J. Epidemiol. Community Health 1989, 43, 237-240. [CrossRef] open in new tab
  23. de Jong, M.; Cranendonk, A.; van Weissenbruch, M.M. Components of the Metabolic Syndrome in Early Childhood in Very-Low- Birth-Weight Infants and Term Small and Appropriate for Gestational Age Infants. Pediatr. Res. 2015, 78, 457-461. [CrossRef] open in new tab
  24. Kesavan, K.; Devaskar, S.U. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatr. Clin. N. Am. 2019, 66, 403-423. [CrossRef] open in new tab
  25. Schoots, M.H.; Gordijn, S.J.; Scherjon, S.A.; van Goor, H.; Hillebrands, J.-L. Oxidative Stress in Placental Pathology. Placenta 2018, 69, 153-161. [CrossRef] open in new tab
  26. Burton, G.J.; Jauniaux, E. Oxidative Stress. Best Pract. Res. Clin. Obstet. Gynaecol. 2011, 25, 287-299. [CrossRef] open in new tab
  27. Theilen, L.H.; Campbell, H.D.; Mumford, S.L.; Purdue-Smithe, A.C.; Sjaarda, L.A.; Perkins, N.J.; Radoc, J.G.; Silver, R.M.; Schisterman, E.F. Platelet Activation and Placenta-Mediated Adverse Pregnancy Outcomes: An Ancillary Study to the Effects of Aspirin in Gestation and Reproduction Trial. Am. J. Obstet. Gynecol. 2020, 223, 741.e1-741.e12. [CrossRef] open in new tab
  28. Krötz, F.; Sohn, H.-Y.; Pohl, U. Reactive Oxygen Species: Players in the Platelet Game. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1988-1996. [CrossRef] open in new tab
  29. Wachowicz, B.; Olas, B.; Zbikowska, H.M.; Buczyński, A. Generation of Reactive Oxygen Species in Blood Platelets. Platelets 2002, 13, 175-182. [CrossRef] open in new tab
  30. Pratico, D.; Iuliano, L.; Pulcinelli, F.M.; Bonavita, M.S.; Gazzaniga, P.P.; Violi, F. Hydrogen Peroxide Triggers Activation of Human Platelets Selectively Exposed to Nonaggregating Concentrations of Arachidonic Acid and Collagen. J. Lab. Clin. Med. 1992, 119, 364-370.
  31. Irani, K.; Pham, Y.; Coleman, L.D.; Roos, C.; Cooke, G.E.; Miodovnik, A.; Karim, N.; Wilhide, C.C.; Bray, P.F.; Goldschmidt- Clermont, P.J. Priming of Platelet AlphaIIbbeta3 by Oxidants Is Associated with Tyrosine Phosphorylation of Beta3. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1698-1706. [CrossRef] open in new tab
  32. Leo, R.; Praticò, D.; Iuliano, L.; Pulcinelli, F.M.; Ghiselli, A.; Pignatelli, P.; Colavita, A.R.; FitzGerald, G.A.; Violi, F. Platelet Activation by Superoxide Anion and Hydroxyl Radicals Intrinsically Generated by Platelets That Had Undergone Anoxia and Then Reoxygenated. Circulation 1997, 95, 885-891. [CrossRef] [PubMed] open in new tab
  33. Yamagishi, S.I.; Edelstein, D.; Du, X.L.; Brownlee, M. Hyperglycemia Potentiates Collagen-Induced Platelet Activation through Mitochondrial Superoxide Overproduction. Diabetes 2001, 50, 1491-1494. [CrossRef] [PubMed] open in new tab
  34. Krötz, F.; Sohn, H.Y.; Gloe, T.; Zahler, S.; Riexinger, T.; Schiele, T.M.; Becker, B.F.; Theisen, K.; Klauss, V.; Pohl, U. NAD(P)H Oxidase-Dependent Platelet Superoxide Anion Release Increases Platelet Recruitment. Blood 2002, 100, 917-924. [CrossRef] [PubMed] open in new tab
  35. Clutton, P.; Miermont, A.; Freedman, J.E. Regulation of Endogenous Reactive Oxygen Species in Platelets Can Reverse Aggrega- tion. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 187-192. [CrossRef] open in new tab
  36. Oparka, M.; Walczak, J.; Malinska, D.; van Oppen, L.M.P.E.; Szczepanowska, J.; Koopman, W.J.H.; Wieckowski, M.R. Quantifying ROS Levels Using CM-H2DCFDA and HyPer. Methods 2016, 109, 3-11. [CrossRef] open in new tab
  37. Ravera, S.; Panfoli, I. Platelet Aerobic Metabolism: New Perspectives. J. Unexplor. Med. Data 2019, 2019, 7. [CrossRef] open in new tab
  38. Perry, C.G.R.; Kane, D.A.; Lanza, I.R.; Neufer, P.D. Methods for Assessing Mitochondrial Function in Diabetes. Diabetes 2013, 62, 1041-1053. [CrossRef] open in new tab
  39. Dmitriev, R.I.; Zhdanov, A.V.; Jasionek, G.; Papkovsky, D.B. Assessment of Cellular Oxygen Gradients with a Panel of Phospho- rescent Oxygen-Sensitive Probes. Anal. Chem. 2012, 84, 2930-2938. [CrossRef] open in new tab
  40. Somkhit, J.; Loyant, R.; Brenet, A.; Hassan-Abdi, R.; Yanicostas, C.; Porceddu, M.; Borgne-Sanchez, A.; Soussi-Yanicostas, N. A Fast, Simple, and Affordable Technique to Measure Oxygen Consumption in Living Zebrafish Embryos. Zebrafish 2020, 17, 268-270. [CrossRef] open in new tab
  41. Hynes, J.; Marroquin, L.D.; Ogurtsov, V.I.; Christiansen, K.N.; Stevens, G.J.; Papkovsky, D.B.; Will, Y. Investigation of Drug- Induced Mitochondrial Toxicity Using Fluorescence-Based Oxygen-Sensitive Probes. Toxicol. Sci. 2006, 92, 186-200. [CrossRef] open in new tab
  42. Will, Y.; Hynes, J.; Ogurtsov, V.I.; Papkovsky, D.B. Analysis of Mitochondrial Function Using Phosphorescent Oxygen-Sensitive Probes. Nat. Protoc. 2006, 1, 2563-2572. [CrossRef] open in new tab
  43. Kondrashina, A.V.; Ogurtsov, V.I.; Papkovsky, D.B. Comparison of the Three Optical Platforms for Measurement of Cellular Respiration. Anal. Biochem. 2015, 468, 1-3. [CrossRef] open in new tab
  44. Fercher, A.; Borisov, S.M.; Zhdanov, A.V.; Klimant, I.; Papkovsky, D.B. Intracellular O 2 Sensing Probe Based on Cell-Penetrating Phosphorescent Nanoparticles. ACS Nano 2011, 5, 5499-5508. [CrossRef] open in new tab
  45. Fercher, A.; O'Riordan, T.C.; Zhdanov, A.V.; Dmitriev, R.I.; Papkovsky, D.B. Imaging of Cellular Oxygen and Analysis of Metabolic Responses of Mammalian Cells. Methods Mol. Biol. 2010, 591, 257-273. [CrossRef] open in new tab
  46. Rumsey, W.L.; Vanderkooi, J.M.; Wilson, D.F. Imaging of Phosphorescence: A Novel Method for Measuring Oxygen Distribution in Perfused Tissue. Science 1988, 241, 1649-1651. [CrossRef] open in new tab
  47. O'Riordan, T.C.; Fitzgerald, K.; Ponomarev, G.V.; Mackrill, J.; Hynes, J.; Taylor, C.; Papkovsky, D.B. Sensing Intracellular Oxygen Using Near-Infrared Phosphorescent Probes and Live-Cell Fluorescence Imaging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R1613-R1620. [CrossRef] open in new tab
  48. Melchinger, H.; Jain, K.; Tyagi, T.; Hwa, J. Role of Platelet Mitochondria: Life in a Nucleus-Free Zone. Front. Cardiovasc. Med. 2019, 6, 153. [CrossRef] open in new tab
  49. Valera, M.-C.; Parant, O.; Vayssiere, C.; Arnal, J.-F.; Payrastre, B. Physiologic and Pathologic Changes of Platelets in Pregnancy. Platelets 2010, 21, 587-595. [CrossRef] open in new tab
  50. Kanat-Pektas, M.; Yesildager, U.; Tuncer, N.; Arioz, D.T.; Nadirgil-Koken, G.; Yilmazer, M. Could Mean Platelet Volume in Late First Trimester of Pregnancy Predict Intrauterine Growth Restriction and Pre-Eclampsia? J. Obstet. Gynaecol. Res. 2014, 40, 1840-1845. [CrossRef] open in new tab
  51. Manten, G.T.R.; Sikkema, M.J.; Voorbij, H.A.M.; Visser, G.H.A.; Bruinse, H.W.; Franx, A. Risk Factors for Cardiovascular Disease in Women with a History of Pregnancy Complicated by Preeclampsia or Intrauterine Growth Restriction. Hypertens. Pregnancy 2007, 26, 39-50. [CrossRef] open in new tab
  52. Bujold, E.; Roberge, S.; Lacasse, Y.; Bureau, M.; Audibert, F.; Marcoux, S.; Forest, J.-C.; Giguère, Y. Prevention of Preeclampsia and Intrauterine Growth Restriction with Aspirin Started in Early Pregnancy: A Meta-Analysis. Obstet. Gynecol. 2010, 116, 402-414. [CrossRef] open in new tab
  53. Blomqvist, L.R.F.; Strandell, A.M.; Baghaei, F.; Hellgren, M.S.E. Platelet Aggregation in Healthy Women during Normal Pregnancy-A Longitudinal Study. Platelets 2019, 30, 438-444. [CrossRef] open in new tab
  54. Can, M.M.; Kaymaz, C.; Can, E.; Tanboga, I.H.; Api, O.; Kars, B.; Ceren Tokgoz, H.; Turkyilmaz, E.; Akgun, T.; Sonmez, K.; et al. Whole Blood Platelet Aggregation Failed to Detect Differences between Preeclampsia and Normal Pregnancy. Platelets 2010, 21, 496-497. [CrossRef] open in new tab
  55. Navaratnam, K.; Alfirevic, A.; Jorgensen, A.; Alfirevic, Z. Aspirin Non-Responsiveness in Pregnant Women at High-Risk of Pre-Eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018, 221, 144-150. [CrossRef] open in new tab
  56. Norris, L.A.; Gleeson, N.; Sheppard, B.L.; Bonnar, J. Whole Blood Platelet Aggregation in Moderate and Severe Pre-Eclampsia. BJOG Int. J. Obstet. Gynaecol. 1993, 100, 684-688. [CrossRef] [PubMed] open in new tab
  57. Lam, F.W.; Vijayan, K.V.; Rumbaut, R.E. Platelets and Their Interactions with Other Immune Cells. Compr. Physiol. 2015, 5, 1265-1280. [CrossRef] open in new tab
  58. Tsoupras, A.; Zabetakis, I.; Lordan, R. Platelet Aggregometry Assay for Evaluating the Effects of Platelet Agonists and Antiplatelet Compounds on Platelet Function in Vitro. MethodsX 2019, 6, 63-70. [CrossRef] open in new tab
Verified by:
No verification

seen 65 times

Recommended for you

The Chitosan-Based System with Scutellariae baicalensis radix Extract for the Local Treatment of Vaginal Infections

2022

Connection matrix theory for discrete dynamical systems

1999

Index filtrations and Morse decomposition for discrete dynamical systems

1999

Modelowanie ciągów danych z użyciem sieci neuronowych

2021
Meta Tags